UiPath Helps Mitsubishi Tanabe Pharma Accelerate Business Operational Efficiency
February 23, 2023Business Services
February 23, 2023 – UiPath (NYSE: PATH), a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, …
NICE recommends first immunotherapychemotherapy combination for neoadjuvant treatment of resectable non-small-cell lung cancer
February 23, 2023Business Services
(Uxbridge, Middlesex, 22 February 2023) – Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care …
LEADING BUILD TO RENT OPERATOR LAUNCHES SECTOR-FIRST PRESCRIPTION SERVICE WITH NATIONAL PHARMACY CHAIN
February 23, 2023Business Services
Moda Living, the UK’s leading developer and operator of rental communities, has today announced a partnership with VideoGP by LloydsPharmacy, …
Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics
February 23, 2023Business Services
Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research …
8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline
February 23, 2023Business Services
LONDON 23rd February 2023
BiomX shares positive data from first bacteriophage trial
February 23, 2023Research and Development
BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …
Redx Pharma agrees to $425m all-share merger with Jounce Therapeutics
February 23, 2023Research and Development
UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …
AstraZeneca signs $63m agreement for gastric cancer treatment
February 23, 2023Medical Communications
AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …
£1.6bn of research and development funding “surrendered” back to UK Treasury
February 23, 2023Medical Communications
A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …
OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology
February 22, 2023Business Services
Nantes, France – February 22, 2023, 6:00 p.m.
Karyopharm and Menarini gain full MHRA approval for multiple myeloma drug
February 22, 2023Research and Development
Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …
FDA grants approval to Beckley Psytech’s short-acting psychedelic trial
February 22, 2023Research and Development
Beckley Psytech, a private, clinical-stage biotech company, announced that the FDA has granted Investigational New Drug (IND) approval for their …
PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA
February 22, 2023Business Services
BASILDON, UK, 22 February 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already …
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter
February 22, 2023Business Services
London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights …
NICE Publishes Reimbursement Recommendation for Translarna™
February 22, 2023Business Services
London, UK, 22nd February, 2023 — PTC Therapeutics, Ltd. today announced the National Institute for Health and Care Excellence (NICE) has published …
Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences
February 22, 2023Business Services
Princeton, United States / Bengaluru, India, February 21, 2023: Indegene, a digital-first, life sciences commercialization company today announced the launch …
Modus Therapeutics announces positive topline data from its Phase 1b LPS provocation study evaluating the potential of sevuparin for treatment of sepsis
February 22, 2023Business Services
STOCKHOLM, SWEDEN – 21 February 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …
FDA approval granted to BD’s HPV assay for use with ThinPrep Pap Test
February 22, 2023Medical Communications
Becton, Dickinson and Company (BD) has received FDA approval for its new HPV assay which will be used in testing …
Pfizer likely to be first to gain FDA approval for new RSV vaccine
February 22, 2023Research and Development
The FDA is expected to approve Pfizer’s new respiratory syncytial virus (RSV) vaccine this summer following its acceptance of the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
